ClinicalTrials.gov
public full text
Public Domain
Duration of IPV Priming and Antibody Decay
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of Australian adults#1005483
- Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects#1089249
- Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant#194799
- A flexible class of latent variable models for the analysis of antibody response data.#288737
- When to Boost: How Dose Timing Determines the Epidemic Threshold#144253
Record · ID 332806 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive